Health Care

Congressman Glenn Grothman (R-Glenbeulah) today issued the following statement after President-elect Trump’s press conference, during which the president-elect questioned pharmaceutical companies’ drug prices: “President-elect Trump was right to call out Big Pharma today for high drug prices and manufacturing practices that take place primarily outside of the U.S. My concerns include… Read more »

The Hill Mylan CEO Should be Ashamed of EpiPen Prices By Congressman Glenn Grothman (R-Wis.) Last week the House Oversight and Government Reform Committee held a hearing on the skyrocketing price of life-saving Epinephrine Auto-Injectors, better known as the EpiPen. This hearing was especially important because EpiPens are predominantly used to keep children alive, which makes… Read more »

(Washington, D.C.) - Congressman Glenn Grothman (R-Glenbeulah) last night questioned officials about the price of EpiPens at a House Oversight and Government Reform Committee (OGR) hearing. Heather Bresch, CEO of Mylan, the pharmaceuticals company that manufacturers EpiPen, and FDA Deputy Director, Center for Drug Evaluation and Research Dr. Doug Throckmorton addressed the skyrocketing… Read more »

(Washington, D.C.) - Rep. Glenn Grothman (R-Wisconsin) released the following statement on the King v. Burwell decision by the Supreme Court to uphold Obamacare subsidies. “The uncertainty working families and employers throughout my district have suffered because of Obamacare is disappointing, to say the least,” said Congressman Grothman. “It is frustrating that once again the Supreme… Read more »